Company: NCEL
Filing Date: 2025-08-06
Form Type: 6-K
Source: 0001213900-25-072320
Chunk: 1

Company: NewcelX Ltd.
Filing Date: 2025-08-06
Form: 6-K
Chunk 1
---
 agreements were waived.

The
foregoing description of the Exchange Agreement does not purport to be complete and is qualified in its entirety by reference to the
full text of the Exchange Agreement, which is filed as Exhibit 99.1 to this Current Report on Form 6-K and incorporated herein by reference

<div align='center'>EXHIBIT INDEX</div>

<div align='center'>2

SIGNATURES</div>

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

| Date: August 6, 2025 | NLS Pharmaceutics Ltd. 
 By:                    | /s/ Alexander Zwyer |                         |
|:---------------------|:-----------------------|:--------------------|:------------------------|
|                      |                        | Name:               | Alexander Zwyer         |
|                      |                        | Title:              | Chief Executive Officer |

<div align='center'>3</div>